Back to School: How biopharma can reboot drug development. Access exclusive analysis here

DIST_0722_scitranslmed.aay1063

siRNAs against plaque-destabilizing molecule CAMK2G for atherosclerosis

Aug 27, 2020 | 10:18 PM GMT

DISEASE CATEGORY: Cardiovascular

INDICATION: Atherosclerosis

Nanoparticles carrying siRNAs against

Read the full 201 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE